CRT 2017 : FDA VALVE - Transcatheter Mitral Therapy: Emerging Therapies for FMR

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA VALVE - Transcatheter Mitral Therapy: Emerging Therapies for FMR

Featuring

  • JoAnn Lindenfeld
  • Vinayak Bapat
  • Ori Ben-Yehuda
  • John Laschinger

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Current State of Therapy for FMR and Evidence to Support a Change – The HF Cardiologist View - JoAnn Lindenfeld
Role of Surgery in FMR - The Surgeon View - Vinayak Bapat
Role of Device Therapy in FMR - The Interventionalist View - Ori Ben-Yehuda
Study Designs for FMR - The FDA View - John Laschinger

Target Audience

Learning Objectives

Related Moments

CRT 2016 Valve & Structural - Pediatric Cardiovascular Device Development: Challenges and Regulatory Pathways
Conference
Pediatric Cardiovascular Device Development: Challenges and Regulatory Pathways at CRT 2016
Live Case Demonstration to Africa PCR (2016) from Hammersmith Hospital
Live Case
Live case demonstration to Africa PCR from Hammersmith Hospital showing contemporary management of diffuse coronary artery disease
Supported By
The Emerging Role Of PCSK9 Inhibitors In Preventive Cardiology
Journal
Article on The Emerging Role Of PCSK9 Inhibitors In Preventive Cardiology
Loading Simple Education